ASND
Ascendis Pharma AS
228.40$
+1.0%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q1 23 | Q2 23 | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 1,886.2% | 1,983.8% | 6,834.1% | 6,789.0% | 9,084.6% | 14,306.4% | 807,744.6% | 11,525,299,587.8% | 54,247,213,088,860.0% | 0.0% | 0.0% | 1,364.9% | 0.0% | 0.0% | 2,584.9% | 4,427.4% | 2,323.5% | 34,607.9% | – | – | – | 71.9% | 62.2% | 17.6% | 11.1% | 22.3% | 13.8% | 27.3% | 15.4% | 14.1% | 7.9% | 31.8% | 19.4% | 8.1% | 17.4% | 19.9% | 10.5% | 11.1% | 8.6% | 9.4% | 9.8% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | -1,264.9% | 100.0% | 100.0% | -2,484.9% | -4,327.4% | -2,223.5% | -34,507.9% | 100.0% | 100.0% | 100.0% | 28.1% | 37.8% | 82.4% | 88.9% | 77.7% | 86.2% | 72.7% | 84.6% | 85.9% | 92.1% | 68.2% | 80.6% | 91.9% | 82.6% | 80.1% | 89.5% | 88.9% | 91.4% | 90.6% | 90.2% | |
| 1,412.3% | 1,916.7% | 5,539.8% | 4,927.9% | 6,697.5% | 10,012.1% | 109,071.4% | 223,527.8% | 157,555.0% | 361.3% | 946.8% | 1,364.9% | 2,062.3% | 2,005.5% | 2,584.9% | 4,427.4% | 2,323.5% | 14,159.3% | 11,816.2% | 8,151.3% | 5,279.5% | 1,340.6% | 1,218.4% | 1,467.3% | 637.2% | 474.4% | 315.9% | 221.6% | 232.0% | 66.0% | 73.7% | 231.9% | 127.2% | 45.6% | 85.8% | 45.5% | 31.3% | 30.6% | 23.0% | 21.6% | 26.0% | |
| 225.9% | 315.1% | 893.8% | 727.7% | 654.4% | 1,459.3% | 16,650.0% | 29,033.3% | 33,980.0% | 79.6% | 192.8% | 341.3% | 445.8% | 681.2% | 805.2% | 1,448.8% | 635.6% | 3,817.9% | 4,992.9% | 3,458.4% | 3,529.6% | 986.4% | 694.5% | 918.6% | 396.8% | 247.0% | 198.1% | 148.3% | 130.1% | 46.5% | 75.4% | 200.8% | 117.8% | 45.3% | 94.7% | 66.9% | 52.3% | 55.1% | 57.9% | 49.8% | 53.5% | |
| 1,638.2% | 2,231.7% | 6,433.6% | 5,655.6% | 7,351.8% | 11,471.4% | 125,721.4% | 252,561.1% | 191,535.0% | 441.0% | 1,139.5% | 1,706.2% | 2,508.2% | 2,686.7% | 805.2% | 1,448.8% | 635.6% | -16,630.7% | 16,809.1% | 11,609.7% | 8,809.1% | 2,327.0% | 1,912.9% | 2,385.8% | 1,034.0% | 721.4% | 514.0% | 369.9% | 364.4% | 112.5% | 143.4% | 438.3% | 247.9% | 91.7% | 185.9% | 113.6% | 84.4% | 84.9% | 81.3% | 72.2% | 79.8% | |
| -1,538.2% | -2,131.7% | -6,333.6% | -5,555.6% | -7,251.8% | -11,371.4% | -125,621.4% | -252,461.1% | -191,435.0% | -341.0% | -1,039.5% | -1,606.2% | -2,408.2% | -2,586.7% | -3,290.1% | -5,776.3% | -2,859.1% | -17,877.2% | -16,709.1% | -11,509.7% | -8,709.1% | -2,299.0% | -1,875.1% | -2,303.5% | -945.1% | -643.7% | -427.8% | -297.2% | -279.8% | -26.6% | -51.2% | -370.2% | -167.3% | 0.2% | -103.2% | -33.5% | 5.1% | 4.0% | 10.1% | 18.4% | 10.4% | |
| 29.7% | 297.8% | 462.9% | 1,404.1% | 647.2% | 3,810.0% | 25,035.7% | 33.3% | 210.0% | 157.7% | 3.6% | 264.5% | 16.4% | 823.2% | 20.1% | 716.7% | 1,449.8% | 7,358.0% | 116.5% | 1,188.0% | 78.8% | 923.6% | 79.1% | 153.1% | 269.8% | 313.0% | 29.3% | 19.7% | 51.0% | 49.8% | 80.5% | 54.5% | 43.8% | 32.6% | 44.4% | 20.9% | 9.2% | 25.0% | 27.3% | 4.2% | 15.5% | |
| -1,566.4% | -1,574.9% | -6,761.6% | -6,924.1% | -7,861.1% | -12,271.8% | -148,150.0% | -127,088.9% | -170,335.0% | -305.0% | -992.0% | -1,836.5% | -1,122.3% | -3,207.0% | -2,849.2% | -6,618.2% | -4,416.4% | -25,977.9% | -8,442.8% | -13,154.8% | -7,218.6% | -2,168.2% | -1,834.5% | -1,320.9% | -1,106.1% | -882.6% | -326.3% | -257.1% | -336.4% | -58.9% | -134.0% | -303.2% | -169.8% | -21.5% | -92.7% | -22.2% | -26.9% | -10.8% | -19.5% | 67.8% | 9.6% | |
| -4.9% | 2.1% | -3.8% | -8.3% | -55.3% | -66.4% | -382.1% | -550.0% | -500.0% | -0.8% | -1.3% | -2.0% | -2.7% | -1.5% | -3.5% | -7.4% | -0.7% | -3.2% | -25.6% | -6.7% | 0.4% | -2.3% | 3.5% | -0.8% | -1.1% | 23.4% | 3.9% | -0.9% | 1.3% | 4.2% | 2.6% | 0.6% | 1.8% | 0.6% | 1.1% | 2.4% | 1.7% | 2.8% | -274.7% | 6.8% | -62.1% | |
| -1,561.5% | -1,577.0% | -6,757.8% | -6,915.8% | -7,805.8% | -12,205.4% | -147,767.9% | -126,538.9% | -169,835.0% | -304.1% | -990.7% | -1,834.4% | -1,119.6% | -3,205.5% | -2,845.7% | -6,610.9% | -4,415.7% | -25,974.8% | -8,417.2% | -13,148.1% | -7,219.0% | -2,165.9% | -1,838.0% | -1,320.1% | -1,105.0% | -905.9% | -330.2% | -256.2% | -337.7% | -63.1% | -136.6% | -303.9% | -171.5% | -22.1% | -93.7% | -24.6% | -28.5% | -13.6% | 255.2% | 61.0% | 71.7% | |
| -1,522.2% | -2,115.1% | -6,253.2% | -5,479.5% | -7,170.5% | -11,301.1% | -122,407.1% | -125,950.0% | -168,955.0% | -338.6% | -964.5% | -1,525.1% | -1,020.5% | -3,112.0% | -2,739.5% | -5,748.4% | -2,884.3% | -32,611.0% | -7,828.4% | -11,612.6% | -6,799.9% | -2,053.7% | -1,690.7% | -1,095.3% | -806.0% | -563.2% | -307.5% | -227.6% | -275.5% | -49.2% | -48.9% | -243.1% | -123.0% | -21.8% | -43.8% | 1.5% | -25.0% | 16.2% | 9.4% | 19.7% | 7.4% |
LTM = last twelve months (sum of the four most recent quarters).
Showing the most recent 40 periods — older statements are on file for this stock.
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.